Skip to main content
Daily Report

Daily Cosmetic Research Analysis

01/31/2025
3 papers selected
3 analyzed

Three impactful studies in aesthetic medicine and dentistry emerged today: a prospective clinical study shows synchronized radiofrequency plus high‑intensity facial electrical stimulation improves upper‑face rhytids and elevates brow position up to 24 weeks; a focused systematic review supports ultrasound to enhance the safety and precision of hyaluronic acid filler injections; and a multi‑center case series delineates histopathologic signatures of adverse reactions to cosmetic fillers, aiding a

Summary

Three impactful studies in aesthetic medicine and dentistry emerged today: a prospective clinical study shows synchronized radiofrequency plus high‑intensity facial electrical stimulation improves upper‑face rhytids and elevates brow position up to 24 weeks; a focused systematic review supports ultrasound to enhance the safety and precision of hyaluronic acid filler injections; and a multi‑center case series delineates histopathologic signatures of adverse reactions to cosmetic fillers, aiding accurate diagnosis.

Research Themes

  • Noninvasive energy-based facial rejuvenation
  • Ultrasound guidance to improve dermal filler safety
  • Histopathologic characterization of cosmetic filler complications

Selected Articles

1. Effect of Synchronized Radiofrequency and High-Intensity Facial Electrical Stimulation (HIFES) of the Upper Face.

69Level IIICohort
Aesthetic surgery journal · 2025PMID: 39888339

In a nonrandomized prospective cohort (n=37), synchronized RF+HIFES significantly reduced forehead and lateral canthal rhytids and raised brow position by 2–3 mm at 24 weeks without altering frontalis muscle or subcutaneous fat thickness. Objective 3D imaging, EMG, and ultrasound corroborated clinical improvements.

Impact: This study supports a noninvasive, energy-based alternative to injectables for upper-face rejuvenation with measurable, durable effects up to 24 weeks. It may broaden treatment options for patients seeking risk mitigation from injection-based procedures.

Clinical Implications: Offer synchronized RF+HIFES as a noninvasive option for forehead and periorbital lines, especially in patients contraindicated for or averse to injectables. Use objective imaging and follow-up at 4–24 weeks to monitor response.

Key Findings

  • Significant improvement in forehead and lateral canthal line severity at 4, 16, and 24 weeks (all P<.001).
  • Medial/central/lateral brow position increased by 3.18/3.02/2.27 mm at week 24 (P<.001).
  • No significant change in frontalis muscle or subcutaneous fat thickness at week 24.

Methodological Strengths

  • Prospective design with predefined follow-up (4, 16, 24 weeks).
  • Objective multimodal assessments: 3D surface imaging, surface EMG, and high-resolution ultrasound.

Limitations

  • Nonrandomized design without a control/sham group.
  • Single-arm study with modest sample size (n=37) limits generalizability.

Future Directions: Conduct randomized, sham-controlled trials with larger cohorts and standardized outcomes; explore dose-response, durability beyond 24 weeks, and mechanistic links between neuromuscular activity and clinical effects.

BACKGROUND: Effects of upper facial aging can present as static forehead and periorbital rhytids as well as soft tissue volume loss. The latter can occur in conjunction with bony changes of the calvarial eyebrow and eyelid ptosis. Injection-based treatments can yield positive outcomes but are not free of procedural risks. OBJECTIVES: The goal of this study was to assess the clinical outcome of synchronized radiofrequency (RF) and high-intensity facial electrical stimulation (HIFES) when targeting the upper face, with special focus on effects on the musculature, subcutaneous fatty layer, and eyebrow position. METHODS: This nonrandomized, prospective study included 37 patients with a mean age of 45.46 years and a mean BMI of 21.84 kg/m2. Patients received 4 synchronized RF and HIFES treatments spaced 7 days apart. Efficacy measurements were taken at 4, 16, and 24 weeks posttreatment with 3-dimensional surface imaging, surface electromyography (EMG), and high-resolution facial ultrasound. RESULTS: Forehead and lateral canthal line severity showed statistically significant improvement at each follow-up visit when compared to baseline, all P < .001. At week 24, the position of the medial/central/lateral eyebrow increased by 3.18/3.02/2.27 mm, respectively, when compared to baseline, with P < .001. At week 24, no statistically significant changes were observed in the thickness of frontalis muscle or the overlying fatty layer. CONCLUSIONS: The application of synchronized RF and HIFES to the frontal region reduced frontal and lateral canthal rhytids and elevated the position of the eyebrow until week 24 after the initial treatment. Based on the results obtained, this noninvasive energy-based treatment option may be a viable alternative to injectable treatments of the upper face when trying to ameliorate the signs of upper facial aging.

2. The role of ultrasound in facial hyaluronic acid dermal filler injections - A review article.

64Level IISystematic Review
Clinical imaging · 2025PMID: 39884168

Across 11 human studies, ultrasound improved safety and precision of facial HA filler injections by enabling preprocedural vascular mapping, real-time guidance, and detection/identification of filler and complications. The review argues ultrasound may become a standard adjunct in aesthetic dermatology.

Impact: By synthesizing emerging evidence, this review supports ultrasound as a practical safety technology for injectors, addressing vascular occlusion and intravascular injection risks—a timely need in a rapidly growing procedural field.

Clinical Implications: Consider routine ultrasound mapping for high-risk zones (glabella, nose, tear trough) and real-time guidance in complex cases; adopt training pathways and protocols to standardize use and reduce vascular complications.

Key Findings

  • Systematic search identified 11 human studies on ultrasound use in facial HA filler procedures.
  • Ultrasound enables precise vascular mapping and real-time detection of filler placement and complications.
  • Evidence suggests reduced risks and improved outcomes when ultrasound is integrated into practice.

Methodological Strengths

  • Focused inclusion criteria with contemporary human studies.
  • Integrates diagnostic (mapping/detection) and interventional perspectives.

Limitations

  • Only 11 studies with heterogeneous designs; limited quantitative synthesis.
  • Not explicitly PRISMA-compliant; potential publication bias and operator dependence.

Future Directions: Prospective comparative trials of ultrasound-guided vs landmark techniques, standardized training/competency metrics, and registries capturing complication rates with/without ultrasound.

Injectable dermal fillers have seen a remarkable rise in popularity in recent years for aesthetic enhancements, such as facial contouring and rejuvenation. Hyaluronic acid (HA)-based fillers are especially favored due to their tolerability, minimal invasiveness, and effectiveness. This review examines the applications of ultrasound in HA dermal filler procedures. A literature search was conducted from February 25 to 26, 2024, using Medline and Google Scholar to identify relevant studies on the use of ultrasound for facial HA dermal fillers. Inclusion criteria included peer-reviewed English language studies from the last decade and involving living human subjects. Eleven studies met these criteria. The findings indicate that ultrasound significantly enhances the accuracy and safety of HA filler procedures by enabling precise vascular mapping, filler detection, and complication detection and identification. By presenting evidence of reduced risks and improved outcomes, this review underscores the potential for ultrasound to become a standard tool in HA filler applications, representing an innovation and a new application for ultrasound in the field of aesthetic dermatology.

3. Adverse Reactions to Cosmetic Fillers in the Oral and Maxillofacial Region: Clinico-Pathological, Histochemical, and Immunohistochemical Characterization.

52Level IVCase series
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2025PMID: 39887813

Across 23 cases from five laboratories, adverse reactions to cosmetic fillers in the oral/maxillofacial region exhibit material-specific histochemical and immunophenotypic signatures (e.g., Alcian blue positivity for hyaluronic acid; refractility of CaHA/PLLA under polarized light; ubiquitous CD68+ macrophages). These features help avoid misdiagnosis and guide management.

Impact: Provides a practical diagnostic framework using a multi-stain and IHC panel to distinguish filler materials and host responses, reducing misdiagnosis of neoplasia and informing targeted management.

Clinical Implications: Use a targeted panel (Toluidine blue, Alcian blue, polarized H&E, CD68/CD3/CD20) when encountering lip nodules or masses in filler-exposed patients to differentiate material types and foreign-body reactions; coordinate with clinicians for material-specific management (e.g., hyaluronidase for HA).

Key Findings

  • Polymethyl-methacrylate was the most frequent filler associated with reactions; foreign-body granulomas were common with PMMA.
  • Hyaluronic acid stained positive with Alcian blue and showed metachromasia with Toluidine blue; CaHA and PLLA were refractile under polarized light.
  • CD68-positive macrophages were numerous in all cases; CD3-positive T cells were present, while CD20-positive B cells were scant or negative.

Methodological Strengths

  • Multi-center sample retrieval with standardized staining and immunohistochemistry.
  • Use of polarized light microscopy to distinguish refractile materials.

Limitations

  • Retrospective, descriptive case series with small sample size (n=23).
  • Limited clinical outcome data and potential selection bias.

Future Directions: Prospective registries linking histopathology with clinical course and treatment response; development of diagnostic algorithms incorporating imaging and histochemical/IHC markers.

BACKGROUND: Cosmetic injections are increasing, as their complications, which can be misdiagnosed as neoplastic lesions. This study aimed to detail clinical, pathological, histochemical, and immunohistochemical features of adverse reactions to cosmetic fillers in the oral and maxillofacial region. METHODS: Samples were retrieved from five pathology laboratories. Hematoxylin-eosin (H&E), Alcian Blue, Sirius Red, and Toluidine blue stains were performed, as well as immunohistochemistry for CD68, CD3, and CD20. H&E was evaluated under polarization. Descriptive statistics were performed. RESULTS: Twenty-three cases were included. Polymethyl-methacrylate was the most common material. Most reactions affected women, lips and were asymptomatic, with a variable time of evolution, presenting as nodules. Materials had different shape and size on H&E. Giant cells were commonly found, except in silicone and hyaluronic acid. Foreign-body granuloma was frequent in polymethyl-methacrylate. Calcium hydroxyapatite and poly-L-lactic acid were refractile under polarized light. Hyaluronic acid and polyacrylamide hydrogel were metachromatic by Toluidine blue. Alcian blue was positive in all cases of hyaluronic acid. Mast cells were detected in all materials, except hyaluronic acid and polyacrylamide hydrogel. Eosinophils were rarer than mast cells. Numerous CD68-positive cells were seen in all cases. All cases had CD3-positive cells, with variable amounts. CD20 was scant or negative in most cases. CONCLUSIONS: An evident macrophage reaction is observed in all aesthetic fillers, frequently associated with giant cell formation. Despite similarities, there are specific features of each material and the host response that assist the correct histopathological diagnosis. Immunohistochemistry for CD68 and Toluidine blue stain are useful in doubtful cases.